Video from December 2014 Health Plan Executive Forum featuring Cathy K. Eddy, President, Health Plan Alliance; Jeremy Nobel, MD, MPH, Medical Director, Northeast Business Group on Health; Matt Salo, Executive Director, National Association of Medicaid Directors; and Danilo Verge, MD, MBA, Vice President, Medical Affairs, Diabetes, Novo Nordisk, Inc.
Partnership Forum: On December 2, 2014, AMCP brought together 60 health care executives from across the nation for a full day of dialogue on critical issues facing the health care system.
Medication Therapy Management Interventions in Outpatient Settings describes intervention components and implementation features for outpatient medication therapy management (MTM) interventions with comprehensive medication review, follow-up, education, and care coordination. Assesses the effectiveness of these MTM interventions on intermediate, patient-centered, or resource utilization outcomes; identifies intervention features and patient characteristics that moderate the effect of an intervention on outcomes; and assess harms associated with interventions.
On August 22, 2014, the DEA issued a final rule (79 FR 49661) in which they rescheduled hydrocodone combination products (HCPs) from schedule III to schedule II of the Controlled Substances Act as of October 6, 2014.
Partnership Forum: On September 9, 2014, AMCP convened a meeting of multiple stakeholders to recommend activities and programs that AMCP can promote to improve pain management, prevent opioid use disorder (OUD), and improve medication-assisted treatment outcomes.